What We're Reading: Page 204
Industry reads hand-picked by our editors
Jun 17, 2020
Jun 16, 2020
-
The New York Times
Most Coronavirus Tests Cost About $100. Why Did One Cost $2,315?
-
Science Translational Medicine
What Might Go Wrong
-
Xconomy
Jazz Pharma Gets Quick FDA OK for New Small Cell Lung Cancer Drug
-
STAT
What’s at stake for industry in the pharmaceutical Space Race for a Covid-19 vaccine
Jun 15, 2020
-
Wall Street Journal
New Rules for Covid Summer: Be Flexible and Vigilant
-
STAT
FDA approves Gardasil 9, the HPV vaccine, to prevent head-and-neck cancer
-
Science
Fifty-four scientists have lost their jobs as a result of NIH probe into foreign ties
-
The New York Times
The Pandemic Claims New Victims: Prestigious Medical Journals
Jun 12, 2020
-
The Washington Post
Hedge fund manager stands to profit on 'flip' of taxpayer-funded coronavirus drug
-
The Boston Globe
Novo Nordisk buys Waltham biotech Corvidia for $725 million
-
Reuters
Bottlenecks? Glass vial makers prepare for COVID-19 vaccine
-
STAT
MIT ends negotiations with Elsevier over research access dispute
Jun 11, 2020
-
The New York Times
In the W.H.O.'s Coronavirus Stumbles, Some Scientists See a Pattern
-
The Boston Globe
Verve raises another $63m to develop gene-editing treatment for heart disease
-
The Wall Street Journal
Hit Hard by Coronavirus, Russia Joins Global Race for a Vaccine
Jun 10, 2020
-
The Wall Street Journal
Coronavirus Vaccine Candidates' Pivotal U.S. Testing to Start This Summer
-
The Harvard Crimson
Former Chemistry Chair Lieber Indicted by Federal Grand Jury for Making False Statements Regarding Relations to China
-
Science
Three big studies dim hopes that hydroxychloroquine can treat or prevent COVID-19
Previous
